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Biologic response of local hemostatic agents used in 
endodontic microsurgery
Appropriate use of local hemostatic agent is one of the important factors on the 
prognosis of endodontic microsurgery. However, most investigations to date focus 
on the hemostatic efficacy of the agents, whereas their biologic characteristics have 
not received enough attention. The purpose of this paper was to review the biologic 
response of local hemostatic agents, and to provide clinical guidelines on their 
use during endodontic microsurgery. Electronic database (PUBMED) was screened 
to search related studies from 1980 to 2013, and 8 clinical studies and 18 animal 
studies were identified. Among the materials used in these studies, most widely-
investigated and used materials, epinephrine, ferric sulfate (FS) and calcium sulfate 
(CS), were thoroughly discussed. Influence of these materials on local tissue and 
systemic condition, such as inflammatory and foreign body reaction, local ischemia, 
dyspigmentation, delayed or enhanced bone and soft tissue healing, and potential 
cardiovascular complications were assessed. Additionally, biological property of their 
carrier materials, cotton pellet and absorbable collagen, were also discussed. Clinicians 
should be aware of the biologic properties of local hemostatic agents and their carrier 
materials, and should pay attention to the potential complications when using them in 
endodontic microsurgery. (Restor Dent Endod 2014;39(2):79-88)
Key words: Calcium sulfate; Endodontic microsurgery; Epinephrine; Ferric sulfate; 
Hemostatic agent; Hemostatics
Introduction
Proper intra-operative hemostasis is one of the important factors that affect the 
prognosis of endodontic microsurgery, because it not only reduces operation time, 
but also enhances proper inspection on root structures and application of root-end 
filling materials.1-3 Therefore, the role of local hemostatic agents is more significant 
in endodontic microsurgery compared to conventional dental surgery. For this reason, 
numerous materials have been proposed and investigated as local hemostatic agents in 
surgical endodontic field.
However, most of the investigations focused on the hemostatic efficacy of the agents, 
whereas their biologic characteristics have not received enough attention. Biologic 
stability is an important requirement of local hemostatic agents, because they are 
placed in direct contact with periapical tissues, including cortical and cancellous 
bone, soft tissue flap, and mental nerve. Inappropriate application of local hemostatic 
agent in such area could result in undesirable local tissue response and systemic 
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complications. Therefore, biologic properties of local 
hemostatic agents need to be considered as well as their 
hemostatic efficacy.
The purpose of this paper is to comprehensively review 
the literature on the biologic response of local hemostatic 
agents, and to provide clinical guidelines on using them 
during endodontic microsurgery.
Review
Electronic database (PUBMED) was screened to identify 
studies which investigated biologic responses of materials 
used as local hemostatic agents, from 1980 to 2013. Only 
in vivo studies which adopted animal or human subjects 
were included. The tissues investigated in these studies are 
osseous tissues (cranium, rib, tibia, ilium, femur, maxilla 
and mandible), soft tissues (schneiderian membrane and 
gingiva), and sciatic nerve. Studies that investigated 
open wounds such as extraction socket, intrabony 
periodontal defect were excluded because most endodontic 
microsurgeries are conducted on periradicular lesion, which 
is basically a closed wound.
Finally, 8 clinical studies (Table 1) and 18 animal studies 
(Table 2) were selected. Among the materials used in 
these studies (Bone wax, oxidized cellulose, gelatin-
based sponge, microfibrillar collagen, ferric sulfate, 
calcium sulfate, aluminum chloride, chitosan sponge, 
and epinephrine), some are rarely used at present due to 
their biologically unfavorable tissue reactions (Bone wax, 
oxidized cellulose, and gelatin-based sponge).4-12
Most widely-investigated and currently used materials 
such as epinephrine, ferric sulfate (FS) and calcium sulfate 
(CS) were selected and discussed further. Influence of these 
materials on local tissue, such as inflammatory and foreign 
body reaction, local ischemia, dyspigmentation, delayed 
or enhanced bone and soft tissue healing were reviewed 
as well. As for the systemic influence, cardiovascular 
complications were discussed related with the use of 
Table 1. Clinical studies evaluated biologic response of materials used as local hemostatic agents
Author
(year of research) Materials used
Number of patients 
and treated site
Observation 
times Study inferences
Papay et al.
(1996)7
Demineralized bone, 
HA granule, Gelfoam, 
Bone wax
14 patients
14 cranial defects
2 - 6 mon after 
surgery
Demineralized bone and HA provide 
greater healing than Gelfoam or 
Bone wax
Leonardis and 
Pecora (1998)13
Surgiplaster (CS)
57 patients
65 sinuses
1 yr after 
implantation
Clinical and radiographic evaluation 
revealed that the augmentation 
procedure with CS resulted in new 
tissue formation within the sinuses
Pecora et al.
(2001)14
Surgiplaster (CS)
20 patients
20 periradicular lesions
6 and 12 mon 
after surgery
CS graft during the conventional 
surgical treatment of through and 
through lesions improve the clinical 
outcome on radiographic analysis
Vickers et al.
(2002)15
Racellet (Epinephrine 
pellet), Viscostat (20% 
FS)
39 patients
periradicular lesion
during surgery
There was no significant change in 
cardiovascular effects when using 
either of tested materials
Vy et al.
(2004)16
Racepinephrine (2.25% 
Epinephrine solution), 
Saline
48 patients
periradicular lesion
during surgery
CollaCote saturated with 2.25% 
racemic epinephrine provides 
excellent hemostasis with no evident 
changes in blood pressure or pulse 
rate
Csillag et al.
(2007)17
0.001%, 0.01%, 0.1% 
of Epinephrine solution
17 patients
gingival sulcus
2, 7, 12, 17 min 
after application
No systemic cardiovascular effect 
was detected.
Scarano et al.
(2010)18
Surgiplaster (CS)
43 patients
66 impacted teeth in 
maxilla and mandible
Orthodontic 
retraction period
No disturbances in the bone healing 
process were observed in any of the 
patients
Scarano et al.
(2012)19
P30 (CS), Viscostat (20% 
FS), Gauze tamponade
24 patients
31 periradicular lesions
during surgery
CS revealed significantly higher 
hemostatic efficacy compared to FS 
and gauze tamponade.
HA, hydroxyapatite; CS, calcium sulfate; FS, ferric sulfate.
Jang Y et al.
http://dx.doi.org/10.5395/rde.2014.39.2.79
81www.rde.ac
Biologic response of local hemostatic agents
Table 2. Animal studies evaluated biologic response of materials used as local hemostatic agents
Author
(year of research)
Materials 
used
Animal model 
used
Observation 
times Study inferences
Nappi and Lehman
(1980)9
Surgicel, Avitene 
(microfibrillar collagen)
16 New zealand 
white rabbits, rib
1, 4, 8 wk after 
surgery
There was no radiographic and histologic evidence 
of new bone formation with the use of Surgicel.
Ibarrola et al.
(1985)5 Bone wax, Gelfoam, Surgicel
50 Sprague-dawley 
rats, tibia
3, 7, 14, 40, 
120 day after 
surgery
Bone wax inhibited osteogenesis. Surgicel markedly 
slowed the rate of repair and caused inflammation. 
Gelfoam was completely resorbed and healing was 
complete at 120 day after surgery
Thaller et al.
(1989)8 Bone wax, Gelfoam, HA
40 White new 
zealand rabbits, 
calvarial bone
3, 4, 8, 16 wk, 
6, 9 mon after 
surgery
Bone wax and Gelfoam inhibit osteoneogenesis to 
varying degrees
Finn et al.
(1992)4
Avitene (microfibrillar 
collagen), Bone wax, 
Gelfoam, Surgicel
4 Dogs, iliac bone 2 mon after surgery
Radiographic and histologic examination showed 
new bone formation in the presence of Avitene, 
Surgicel, and Gelfoam
Bone wax showed an intense foreign-body reaction 
and lack of bone reformation
Lemon et al.
(1993)20 Aqueous FS solution
10 New zealand 
white rabbits, 
mandible
18 and 46 day 
after surgery
FS does damage bone and delay healing when used 
in maximum amounts and left in situ
Jeansonne et al.
(1993)21 15.5% FS solution
12 New zealand 
white rabbits, 
mandible
18 and 46 day 
after surgery
FS did not cause persistent inflammation or delay 
osseous repair when adequately curetted and 
irrigated from the surgical site 
Pecora et al.
(1997)22 Prehardened CS disk
40 Sprague-dawley 
rats, mandible
3, 9, 18, 22 wk 
after surgery
CS barriers can exclude connective tissues, allowing 
bone regeneration
Clokie et al. 
(2002)23
Osteoset (CS), DynaGraft 
Putty (demineralized bone 
matrix), Norian CRS (CPC), 
Bone source (CPC)
30 New zealand 
white rabbits, 
parietal bone
6 and 12 wk 
after surgery
Defects filled with CS healed with fibrous scar
Defects reconstructed with the DynaGraft Putty 
healed with bone throughout the entire defect
Miller et al.
(2002)24
1 : 10,000 Epinephrine 
solution
11 Sprague-dawley 
rats, sciatic nerve
Baseline, 
Immediate, 
1, and 5 min 
after application
Topical epinephrine at a standard solution (1 : 
10,000) does not lead to clinically significant nerve 
conduction abnormalities
Murashima et al.
(2002)25 Medical grade CS
11 Beagle dogs, 
periradicular leison
8 and 16 wk 
after surgery
The use of CS was effective in bone regeneration 
on both large osseous defects and ‘through and 
through’ osseous defects
CS was less effective in osseous defects 
communicating with the gingival sulcus
Strocchi et al.
(2002)26
Surgiplaster (CS), Autologous 
bone
9 New zealand 
rabbits, tibial 
metaphysis
4 wk after 
surgery CS seems to stimulate angiogenesis.
Walsh et al.
(2003)27
Osetoset (CS), Autogenous 
bone
12 Cross-bred 
wethers, femoral 
condyle
Immediately, 
12 wk after 
surgery
New thick bone formation was seen in defects filled 
with CS pellets 
Increased immunostaining for BMP-2, 7, TGF-β, and 
PDGF was seen in defects filled with CS pellets alone 
and in combination with autograft
Apaydin and 
Torabinejad
(2004)28
Capset (CS)
Beagle dogs, 
24 periradicular 
defects
4 mon after 
surgery
CS placement in osteotomy sites after periradicular 
surgery does not significantly affect periradicular 
healing
Orsini et al.
(2004)29 Surgiplaster (CS)
8 New zealand 
rabbits, tibial 
metaphysis
2, 4 wk after 
surgery
Both CS cement and CS beads showed high 
biocompatibility, appearing to promote new bone 
formation in the rabbit model
Von arx et al.
(2006)30
Bone wax, Stasis (FS), 
Expasyl (Aluminum chloride)
6 Burgundy rabbits, 
calvarium
3, 12 wk after 
surgery
Inflammatory tissue response was present in 
sites treated with Bone wax or Expasyl at 12 wk 
postoperatively
Alkan et al.
(2007)10
Surgicel, Gelatamp (gelatine 
sponge), Bone wax, Lyostypt 
(bovine collagen)
25 Wistar Rat, 
sciatic nerve
Immediately, 
4 wk after 
surgery
Bovine collagen is the most suitable hemostatic 
agent applicable for peripheral nerves
Jensen et al.
(2009)31
Expasyl (Aluminum 
chloride), Stasis (FS), 
Spongostan (gelatin-based 
sponge), Epinephrine, 
Electrocauterization
6 Burgundy rabbits, 
calvarium 
3 and 12 wk 
after surgery
Expasyl + Stasis and electrocauterization were 
accompanied by unfavourable tissue reactions, 
whereas Spongostan + epinephrine showed only mild 
adverse tissue reactions
Azargoon et al.
(2011)32
15.5% FS solution, HemCon 
dental dressing (chitosan 
sponge)
12 New zealand 
white rabbit, 
mandible
21 day after 
surgery
There was no significant difference in hemostatic 
efficacy or wound healing between HemCon and 
ferric sulfate
HA, hydroxyapatite; FS, ferric sulfate; CS, calcium sulfate; CPC, calcium phosphate cement.
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epinephrine. Additionally, biological properties of their 
carrier materials such as cotton pellet and absorbable 
collagen were discussed.
Epinephrine
Epinephrine is a sympathomimetic agent, which 
act as agonist of α and β adrenergic receptors.33 It 
induces vasoconstriction by binding to α1 receptor, and 
vasodilation by binding to β2 receptor. As α receptors 
predominate in oral mucosa, submucosa, and periodontium 
compared to β2 receptor, epinephrine mainly behaves as 
potent vasoconstrictor in the oral cavity.34-36
1. Hemostatic property
Epinephrine has been recommended as effective local 
hemostatic agent in endodontic surgery.1,2,34,37,38 Vickers et 
al. reported superior hemostatic efficacy of epinephrine 
above 20% FS during endodontic surgery.15 Vy et al. also 
reported that complete hemostasis was successfully 
established during 39 of 42 cases of periradicular surgery 
by epinephrine application alone.16
2. Biological response
1) Local tissue ischemia
Adverse local tissue reaction has rarely been reported 
with clinical application of epinephrine. However, because 
of its strong vasoconstrictive effect, epinephrine has been 
associated with local tissue ischemia and subsequent 
tissue necrosis on gingiva, bone tissues, and sensory nerve. 
In fact, such concerns have already been recognized in 
the medical field. Safety of epinephrine injection related 
with subsequent local tissue ischemia and tissue necrosis 
at end-perfusion areas (i.e. finger, foot, nose) has been 
in debate for decades in plastic surgery. However, recent 
large-scale clinical studies are now arguing that low 
concentration (1 : 100,000 - 1 : 80,000) of epinephrine 
injection is safe in ear, nose, hand and finger region.39-42 
Denkler evaluated 21 cases of digital gangrene associated 
with epinephrine injection by reviewing the literatures 
from 1880 to 2000, and suggested that uncontrolled 
concentration of epinephrine caused by manual dilution 
as one of the reasons.43 There are few studies that 
investigated the effect of epinephrine on sensory nerve 
damage. Miller et al. reported that topical epinephrine (1 
: 10,000) application did not cause significant alteration 
on conduction latency and amplitude in rat model, with no 
clinically significant nerve conduction abnormalities.24 This 
finding could be an implication on predicting the influence 
of topically-applied epinephrine on exposed mental nerve 
during endodontic microsurgery.
However, these results cannot be directly applied 
to endodontic microsurgery, because epinephrine 
concentration used in endodontic microsurgery is much 
higher (about 1 : 1,000) and the amount is much larger 
(3.9 - 104 folds) than those of other dental surgeries.44 
Moreover, Csillag et al. reported that effect of epinephrine 
on human gingival blood flow is dose-related, and observed 
that local gingival ischemia was maintained until the study 
termination (17 minutes) when high concentration (0.1 
and 0.01%) of epinephrine was applied into the gingival 
sulcus.17 Therefore, probability of epinephrine causing 
irreversible local tissue ischemia on bone or gingival 
tissues during endodontic microsurgery still remains.
2) Cardiovascular complications
Epinephrine strongly stimulates cardiac function by 
increasing both cardiac output and pulse rate when it is 
bound to β1 receptor.33 Thus, epinephrine is closely related 
to alteration of cardiovascular function when it enters 
systemic circulation.45 Jang and Kim stated that systemic 
influence of epinephrine could be increased in endodontic 
microsurgery, because endodontic microsurgery reveals two 
different aspects compared to other dental surgeries in 
epinephrine application, such as, dose and administration 
route.44 It is reported that 3.9 - 104 times more 
epinephrine is used in endodontic microsurgery compared 
to conventional dental surgery.44 Also, intraosseous route 
has a greater influence on systemic circulation compared 
to mucosal or submucosal routes.46,47 However, such 
concern for systemic complication has not been reproduced 
in clinical situations up to date. Out of the existing 
clinical studies which investigated cardiovascular effect 
of topically-applied epinephrine, none reported significant 
cardiovascular response during the surgical procedure.15,16,48 
Vy et al. suggested that systemic absorption of epinephrine 
would be limited because first-applied epinephrine causes 
immediate vasoconstriction on the bone surface.16
 Nevertheless, it should be noted that cardiovascular 
emergencies have been continuously induced during 
surgeries in oral & maxillofacial region, even at low 
concentrations (1 : 100,000 - 1 : 80,000).49-52 Therefore, 
cardiovascular stability of epinephrine is still unclear, and 
further investigation is needed to identify the amount of 
systemic absorption and the cardiovascular influence of 
epinephrine during endodontic microsurgery.
3. Clinical suggestion
There is no clinical evidence that epinephrine induce 
ischemic necrosis of periapical tissues, or cardiovascular 
complications in endodontic microsurgery up to date. 
However, it should be noted that epinephrine is applied in 
remarkably high concentration and volume in endodontic 
microsurgery, and the administration route is influential 
to systemic circulation. Therefore, it is imperative to 
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restrict epinephrine administration to minimal extent until 
further investigation guarantees the safety of epinephrine 
from local and systemic complications. Kim and Rethnam 
recommended the use of only one epinephrine pellet 
and subsequent sterile dry cotton pellets.1 For situation 
which requires larger amount of epinephrine, clinician 
should calculate the total amount of applied epinephrine. 
Commercial products such as Racellet pellet (Pascal 
Company, Inc., Bellvue, WA, USA) would be useful for this 
estimation.
Ferric sulfate
FS (Fe2(SO4)3) is a chemical compound. Since it was first 
introduced in the dermatologic field as Monsel’s solution 
in 1856, FS has been popularly used in the dental field as 
local hemostatic agent during crown and bridge impression, 
pulpotomy, and periradicular surgery.1,2,34,53-55 In the clinical 
setting, 15 - 20% FS solution is commonly used.15,32
1. Hemostatic property
Ease of application is an obvious advantage of FS as 
local hemostatic agent. When applied on bleeding spot, FS 
immediately forms dark-brownish clot without additional 
pressure, and the hemostasis could be maintained up to 5 
minutes.1,20 This is attributed to the hemostatic mechanism 
of FS (Table 3).
However, hemostatic ability of FS is not superior 
compared with other local hemostatic agents, according 
Table 3. Properties of epinephrine, ferric sulfate, and calcium sulfate as local hemostatic agent
Epinephrine Ferric sulfate Calcium sulfate
Commercial 
products
− Racellet pellet (Pascal Company, 
Inc, Bellvue, WA, USA)15,34
− Racepinephrine (Nephron 
Pharmaceutical Corp, Orlando,   
FL, USA)16
− Bosmin (Jeil Inc, Seoul, Korea)37,38
− Stasis (Belport Co, Camarillo, CA, 
USA)30,31,56,57
− Viscostat (Ultradent products, Inc, 
South Jordan, UT)15,19
− Astringedent (Ultradent products, 
Inc, South Jordan, UT)38,56
− OsteoSet (Wright Medical 
Technology Inc, Arlington, TN, 
USA)23,27
− Surgiplaster (Classimplant, Rome, 
Italy)13,14,26,29
− Capset (Lifecore Biomedical, 
Chaska, MN, USA)28
Mechanism of 
hemostatic action
− Induce local vasoconstriction by 
binding to α1 adrenergic receptor 
− Mechanical compression during 
placement
− Protein agglutination caused by 
acidic pH of the solution, and 
the reaction between ferric and 
sulfate ions, and blood proteins1,58
− Mechanical obstruction of the 
capillary orifices by protein plug1
− Mechanical compression during 
placement18,19
− Mechanical blockage of vascular 
orifices after setting1
− Activation of intrinsic coagulation 
pathway18,19,64,65
Local tissue 
response
Local ischemia Osseous reaction Osseous & soft tissue reaction
− Low concentration (1 : 800,000 
- 1 : 100,000) of epinephrine 
injection does not induce 
irreversible local ischemia in ear, 
nose, hand and finger region39-42
− Irreversible local ischemia has not 
been reported in oral cavity
− Persistent inflammation or 
delayed osseous healing when 
used in maximum amounts20
− Negative tissue reaction of FS was 
reduced by adequate curettage 
and irrigation, or mechanical 
freshening of the bone cavity21,30,31
− Almost no inflammatory response66
− Growth factor release (BMP-2, 
BMP-7, TGF-β, and PDGF)27 
− Angiogenesis26
− Fibroblast migration67 
− Resorbed in 1 to 3 mon29,32,68
Nerve reaction Soft tissue reaction
− Topically-applied epinephrine 
(1 : 10,000) application did not 
cause clinically significant nerve 
conduction abnormalities24 
− Delayed re-epithelization59-61
− Dyspigmentation on soft 
tissue59,62,63
Systemic 
response
Cardiovascular complication has 
been reported in several cases of 
oral & maxillofacial surgeries, but 
not in clinical trials15,16,48-52
Not reported Not reported
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to the existing clinical and in vivo studies. Von Arx et al. 
compared the hemostatic efficacy of FS with bone wax and 
aluminium chloride in rabbit calvarium model, and reported 
that bleeding reduction of FS group is not significantly 
different from other experimental groups.30 In similar 
rabbit model, Scarano et al. reported that FS shows inferior 
hemostatic ability compared to calcium sulfate.19 Also a 
clinical study by Vickers et al. that used FS in periradicular 
surgery reported that FS revealed less hemostatic efficacy 
than topically-applied epinephrine.15
2. Biological response
Lemon et al. tested the effect of FS on osseous wound 
healing in rabbit model.20 FS-treated group revealed 
extensive foreign body reaction, healing retardation, and 
abscess formation in some cases when FS was used in 
maximum amounts and left in the bone cavity for 18 and 
46 days. In another corresponding study, Jeansonne et 
al. reported that such persistent inflammation or delayed 
osseous healing were not noticeable when FS was properly 
curetted and irrigated from the bone cavity.21 Von Arx 
et al. also showed that negative tissue reaction of FS 
could be minimized when FS was adequately removed by 
additional curettage and saline irrigation.30 Jensen et al. 
recommended mechanical freshening of the bone cavity 
after the surgical procedure to reduce undesirable tissue 
reactions.31
However, it should be noted that unset retrograde filling 
material could be damaged by the flushing of irrigating 
solution or water spray. Therefore such managements (i.e, 
mechanical freshening, sufficient curettage and irrigation) 
are not recommended when retrograde filling material with 
long-setting time such as ProRoot MTA (Dentsply Tulsa 
Dental, Johnson City, TN, USA) is used.31
Influence of FS on the soft tissue has not been broadly 
investigated in the dental field. However literatures from 
dermatologic surgery could be helpful because Monsel’s 
solution (20% ferric subsulfate) has been popularly used 
and investigated in the dermatologic field.69,70 Although 
being an effective local hemostatic measure, Monsel’s 
solution resulted in several post-operative complications 
such as delayed re-epithelization and dyspigmentation 
on soft tissue.59-63 Armstrong et al. compared the effect 
of collagen matrix and Monsel’s solution on punch biopsy 
wounds, and observed more inflammation, higher incidence 
of wound infection, and slower re-epithelialization rate on 
the group treated by Monsel’s solution at 4 weeks.61
3. Clinical suggestion
Although adverse tissue reaction from FS could be 
reduced by thorough curettage and irrigation on surgical 
site, it draws more uncertainty on normal healing compared 
with other local hemostatic agents. Also, retro-filling 
material with long-setting time could be damaged by 
such additional removal procedure. Therefore, FS should 
be applied in bone cavity to a minimum extent. Kim 
and Kratchman recommended to apply FS only on small 
bleeding points of cortical bone surface.34 It should be 
noted that FS also interferes soft tissue healing. Therefore 
clinicians should carefully handle FS and avoid contact 
with the surgical flap during endodontic microsurgery.
Calcium sulfate
CS naturally exists as the dihydrate (CaSO4·2H2O), which 
is also known as ‘gypsum’. Through the heating process 
called calcination, CS dihydrate is transformed to CS 
hemihydrate (CaSO4·½H2O), which is known as ‘plaster of 
paris’.66 
CaSO4·2H2O + heat → CaSO4·½H2O + 1½H2O 
Most medical products are manufactured in hemihydrate 
form. When mixed with water, hemihydrate rapidly reverts 
to the dihydrate form, constructing rigid crystal network in 
vivo.66
CaSO4·½H2O + 1½H2O → CaSO4·2H2O
1. Hemostatic property
Although CS has been used as a biomaterial in both 
dental and medical area for decades, recently it received 
attention as local hemostatic agent. Kim and Rethnam 
stated the usefulness of CS as local hemostatic agent 
during endodontic microsurgery in 1997.1 They pointed out 
excellent biocompatibility, resorbability, and inexpensive 
price as the advantages of CS,1 and recommended its 
application when the size of the periapical bony crypt is 
large.34 Scarano et al. reported that CS reveals significantly 
better hemostatic ability above FS or gauze tamponade in 
simulated bone cavity on rabbit model.19 Scarano et al. also 
tested the effectiveness of CS to maintain surgical field dry 
during surgical exposure and orthodontic bracket bonding 
of impacted teeth.18 CS-applied group showed superior 
result on bonding prognosis, compared to control group 
which only applied gauze tamponade.
2. Biological response
CS is known to be absorbed rapidly and completely in 
vivo, causing almost no inflammatory response.66 Moreover, 
CS is reported to be positively related to growth factor 
release (BMP-2, BMP-7, TGF-β, and PDGF), angiogenesis, 
and fibroblast migration, which could enhance bone 
healing.26,27,67 For this reason, CS has been broadly 
investigated and shows successful clinical outcomes in 
dental fields for treating periodontal intrabony defect, 
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sinus augmentation,  and guided tissue regeneration.13,71-74. 
Effectiveness of CS as bio-graft material has also been 
advocated in surgical endodontic field. Murashima et al. 
reported that large periradicular defects and through-and-
through periradicular defects were adequately healed by 
CS placement in beagle dog model.25 Pecora et al. also 
reported that CS grafts improved the clinical outcome 
of periradicular surgery in through-and-through defects 
compared to control group.14 Some studies are still 
questioning the effectiveness of CS as bone graft material, 
and comment that CS does not significantly improve bony 
healing.23,28,75 Nevertheless, it is mostly accepted that 
application of calcium sulfate does not retard bony healing. 
These results indicate that CS could be used as hemostatic 
agent in periradicular surgery without biologically negative 
effects, which is agreed upon by Apaydin and Torabinejad.28
3. Clinical suggestion
CS reveals many qualities close to the ideal local 
hemostatic agent, which shows highly biocompatible 
and bio-resorbable properties, effective achievement and 
maintenance of hemostasis, ease of manipulation, and 
cost-effectiveness. CS application seems to be a desirable 
treatment option especially in the large lesions and the 
through-and-through lesions that needs additional bone 
graft or mechanical barrier.
Carrier materials
Several local hemostatic agents prepared in liquid form 
(i.e. epinephrine solution, FS solution) needs carrier 
material to be delivered to the surgical site. Such carrier 
materials directly contact the surgical site, and often 
left in the bony crypt during the surgical procedure, to 
maintain hemostasis and to prevent excess filling materials 
from falling into the cavity. Therefore, biologic response 
of carrier material is another important issue for adequate 
healing of periapical structures.
1. Cotton pellet
Cotton pellet is one of the most widely-used carrier 
materials in endodontic microsurgery. However, because 
it is not bio-resorbable, the remaining cotton fiber has 
been suggested as a factor that causes inflammation and 
healing retardation.16 Several case reports are warning the 
undesirable tissue reaction induced by cotton remnants.76,77 
Sexton et al. reported intensive foreign body reaction 
from a remaining cottons sponge, which developed a 
large soft tissue mass in femur, and termed the mass 
as ‘cottonballoma’.77 Kalbermatten et al. also reported 
pseudotumor of femur, which was induced by remnants of 
the cotton sponge.76
2. Absorbable collagen sponge
As bio-incompatible nature of cotton materials draws 
more uncertainty on periapical healing, absorbable collagen 
materials are being highlighted as carrier material. Collagen 
sponges already have been actively used in dental area, 
such as revascularization and perforation repair procedures, 
due to its space-maintaining and bio-absorbable 
property.78,79 Collagen seems to be a suitable material as 
carrier material for local hemostatic agents in endodontic 
microsurgery. Collagen sponge is able to contain plenty 
of fluid in limited volume, and it could be removed with 
no residual fiber or debris.16,80,81 Most important point is 
that collagen dose not interfere with bone and soft tissue 
healing, because it is biologically absorbed even when it is 
left in the surgical cavity.82
3. Clinical suggestion
Vy et al. successfully achieved local hemostasis during 
endodontic surgery by application of absorbable collagen 
sponges (CollaCote, Integra LifeSciences Corporation, 
Plainsboro, NJ, USA) soaked in 2.25% racemic epinephrine, 
reducing the potential complications by remaining cotton 
fiber.16 Biocompatible carrier material such as absorbable 
collagen would be an alternative to present cotton-based 
carrier materials. Cotton pellet could be used as carrier, if 
there are no alternatives. However, all of the cotton fibers 
should be removed from the bony crypt prior to closure 
of the surgical site to prevent interference of periapical 
healing.
Conclusions
Use of local hemostatic agent is essential for proper 
hemostasis during endodontic microsurgery. However, 
inadequate selection and application of local hemostatic 
agents could cause undesirable biological responses, 
deteriorating the prognosis of endodontic microsurgery. 
Although hemostatic efficacy is an important requirement 
of local hemostatic agents for proper management of 
root during endodontic microsurgery, adequate healing of 
periapical structures cannot be guaranteed unless biologic 
stability of local hemostatic agents is considered. Therefore, 
clinicians should be aware of the biologic properties of 
local hemostatic agents and their carrier materials, and 
should pay attention to the potential complications when 
using them on endodontic microsurgery. Further researches 
are needed to ensure the safety of local hemostatic agents, 
and to enhance biologic properties of the materials, making 
them closer to the ideal local hemostatic agent.
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